Compugen Ltd
CGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001119774
In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.69K in total
- 1
- 13F holdersQ2 2026, +4 vs. previous quarter
- 83
- 13F valueReported value at the end of Q2 2026
- $30.3M
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding CGEN, Q2 2026
1 superinvestor reports holding Compugen Ltd on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Compugen Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 (view filing)4:01 PM ET | Jul 9 | 4 days | Levine ZuritSVP, Business Development | SSale | −1.88K | $2.50 | −$4.69K | −6.0%29.4K after | 10b5-1 |
| Apr 27, 2026 (view filing) | Apr 24 | 3 days | Levine ZuritSVP, Business Development | SSale | −2.00K | $3.20 | −$6.40K | −6.4%29.4K after | 10b5-1 |
| Apr 27, 2026 (view filing) | Apr 24 | 3 days | Ophir EranPresident and CEO | SSale | −5.00K | $3.20 | −$16.0K | −30.5%11.4K after | 10b5-1 |
| Apr 15, 2026 (view filing) | Apr 14 | 1 day | Ophir EranPresident and CEO | SSale | −5.00K | $2.90 | −$14.5K | −30.5%11.4K after | 10b5-1 |
| Apr 15, 2026 (view filing) | Apr 14 | 1 day | Levine ZuritSVP, Business Development | SSale | −2.00K | $2.80 | −$5.60K | −6.4%29.4K after | 10b5-1 |
| Apr 15, 2026 (view filing) | Apr 10 | 5 days | Levine ZuritSVP, Business Development | SSale | −3.13K | $2.56 | −$8.00K | −9.6%29.4K after | Amended10b5-1 |
| Apr 9, 2026 (view filing) | Apr 7-8 | 2 days | Levine ZuritSVP, Business Development | SSale | −7.88K | $2.38 | −$18.8K | −21.1%29.4K after | 2 lots10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Levine ZuritSVP, Business Development | SSale | −3.50K | $2.20 | −$7.70K | −10.6%29.4K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Ophir EranPresident and CEO | SSale | −5.63K | $2.21 | −$12.4K | −33.1%11.4K after | 10b5-1 |
| Mar 30, 2026 (view filing) | Mar 26 | 4 days | Levine ZuritSVP, Business Development | SSale | −11.9K | $2.04 | −$24.2K | −28.8%29.4K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Compugen Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Silverarc Capital Management, LLC | 3,184,257 | $6.81M | 0.76% | −131,588−4.0% | Reduced |
| Renaissance Technologies LLC | 1,877,500 | $4.02M | 0.01% | +244,512+15.0% | Added |
| Morgan Stanley | 1,051,986 | $2.25M | 0.00% | −1,243−0.1% | Reduced |
| Nomura Asset Management International Inc. | 1,020,000 | $2.18M | 0.00% | 00.0% | Unchanged |
| Taylor Frigon Capital Management LLC | 842,181 | $1.80M | 0.84% | −5,862−0.7% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 786,536 | $1.68M | 0.01% | −263,337−25.1% | Reduced |
| Altshuler Shaham Ltd | 521,625 | $1.12M | 0.01% | +517,625+12,940.6% | Added |
| Two Sigma Investments, LP | 512,419 | $1.10M | 0.00% | −9,168−1.8% | Reduced |
| State Street Corp | 415,668 | $889.5K | 0.00% | +302+0.1% | Added |
| Atom Investors LP | 303,526 | $649.5K | 0.06% | +258,155+569.0% | Added |